Bill > H4200

This bill establishes a pilot program allowing for the supervised use of psychedelics in mental health treatment within licensed clinical facilities. Specifically, the Department of Public Health will issue permits to up to three mental health clinics to administer psychedelic materials to clinically appropriate patients under a multi-disciplinary care team's supervision. The pilot program aims to develop best practices for psychedelic mental health treatment and collect patient outcome data. Participating clinics must be exclusively focused on mental health services and cannot be affiliated with cannabis, pharmaceutical, or psychedelic molecule development industries. The program will require comprehensive regulations covering patient assessment, clinical staff composition, medical coordination, and psychedelic storage and administration. Participating organizations must track and share patient care data related to treating conditions like depression, anxiety, post-traumatic stress disorder, and substance use disorder. The goal is to help establish a safe and effective framework for psychedelic-assisted mental health treatment in Massachusetts by gathering empirical evidence and developing rigorous clinical protocols.

Health and Social Services

https://malegislature.gov/Bills/194/H4200